The influence of erythropoietin on the vascular responses of rat resistance arteries

Experimental Physiology

Volumn 84, Issue 5, 1999, Pages 917-927

  Wu, Xiao Chun ^a   Richards, Nicholas T ^b   Johns, Edward J ^a  

^a Medical School   (United Kingdom)

^b QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ACETYLCHOLINE; BRADYKININ; ERYTHROPOIETIN; N(G) NITROARGININE METHYL ESTER; NITROPRUSSIDE SODIUM; NORADRENALIN; POTASSIUM CHLORIDE; SEROTONIN;

ANIMAL TISSUE; ARTERY TONE; ARTICLE; BLOOD VESSEL REACTIVITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; HYPERTENSION; KIDNEY ARTERY; MALE; MESENTERIC ARTERY; NONHUMAN; RAT; RESISTANCE BLOOD VESSEL; VASOCONSTRICTION; VASODILATATION;

EID: 0032856403     PISSN: 09580670     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0958067099019107     Document Type: Article

References (25)

1. AZZADIN, A., BIALKOWSKA, A., BUCZKO, W., MALYSZKO, J., KALINOWSKI M. & MYSLIWIEC, M. (1992). Serotonergic mechanism of erythropoietin-induced hypertension. Nephrology Dialysis Transplantation 7, 882-883.
2. AZZADIN, A., MYSLIWIEC, J., WILLNY, T., MYSLIWIEC, M. & BUCZKO, W. (1995). Serotonin is involved in the pathogenesis of hypertension developing during erythropoietin treatment in uremic rats. Thrombosis Research 77, 217-224.
3. BODE-BÖGER, S. M., BOGER, R. H., KUHN, M., RADERMACHER, J. & FROLICH, J. C. (1992). Endothelin release and shift in prostaglandin balance are involved in the modulation of vascular tone by recombinant erythropoietin. Journal of Cardiovascular Pharmacology 20, 25-28.
4. BODE-BÖGER, S. M., BOGER, R. H., KÜHN, M., RADERMACHER, J. & FROLICH, J. C. (1996). Recombinant-human-erythropoietin enhances vasoconstrictor tone via endothelin-1 and constrictor prostanoids. Kidney International 50, 1255-1261.
5. BUND, J., HEAGERTY, A., EDMUNDS, M. & WALLS, J. (1989). Erythropoietin does not induce vasoconstriction directly in human subcutaneous resistance arterioles. Nephron 53, 173.
6. CARLINI, R. G., GUPTA, A., LIAPIS, H. & ROTHSTEIN, M. (1995). Endothelin-1 release by erythropoietin involves calcium signaling in endothelial-cells. Journal of Cardiovascular Pharmacology 26, 889-892.
7. CHAMPION, H. C., SANTIAGO, J. A., CZAPLA, M. A., BIVALACQUA, T. J., ILGENPRITZ, C. & KADOWITZ, P. J. (1997). Comparison of responses to T-kinin and bradykinin in the mesenteric vascular bed of the cat. Peptides 18, 1357-1364.
8. CRUZ, M. A., GONZALEZ, C., GALLARDO, V., ALBORNOZ, J., MUNOZ, M. E. & LAGOS, M. (1995). Endothelial modulation of vascular tone and 5-hydroxytryptamine-induced responses in human chorionic arteries and veins. General Pharmacology 26, 1571-1577.
9. DORN, G. W., BECKER, M. W. & DAVIS, M. G. (1992). Dissociation of the contractile and hypertrophic effects of vasoconstrictor prostanoids in vascular smooth-muscle. Journal of Biological Chemistry 267, 24897-24905.
10. GAMBONE, L. M., MURRAY, P. A. & FLAVAHAN, N. A. (1997). Synergistic interaction between endothelium-derived NO and prostacyclin in pulmonary artery: Potential role for K-ATP(+) channels. British Journal of Pharmacology 121, 271-279.
11. HEIDENREICH, S., RAHN, K. H. & ZIDEK, W. (1991). Direct vasopressor effect of recombinant-human-erythropoietin on renal resistance vessels. Kidney International 39, 259-265.
12. HUANG, C. L., DAVIS, G. & JOHNS, E. J. (1993). Role of haematocrit in mediating the actions of chronic erythropoietin treatment on blood-pressure and renal hemodynamics in the rat. Clinical Science 85, 717-724.
13. LÜSCHER, T. F., WENZEL, R. R. & NOLL, G. (1995). Local-regulation of the coronary circulation in health and disease - role of nitric-oxide and endothelin. European Heart Journal 16, 51-58.
14. MULVANY, M. J. & HALPERN, W. (1977). Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circulation Research 41, 19-26.
15. NEUSSER, M., TEPEL, M. & ZIDEK, W. (1993). Erythropoietin increases cytosolic-free calcium-concentration in vascular smooth-muscle cells. Cardiovascular Research 27, 1233-1236.
16. NOSSAMAN, B. D., KAYE, A. D., FENG, C. J., KANG, B. & KADOWITZ, P. J. (1997). Analysis of responses to bradykinin in the rat hindquarters vascular bed. American Journal of Physiology 272, R631-639.
17. ONGIL, S. L., SAURA, M., LAMAS, S., PUYOL, M. R. & PUYOL, D. R. (1996). Recombinant-human-erythropoietin does not regulate the expression of endothelin-1 and constitutive nitric-oxide synthase in vascular endothelial-cells. Experimental Nephrology 4, 37-42.
18. RUDKO, I. A., BALASHOVA, T. S., KUATIEV, A. A. & ERMOLENKO, V. M. (1994). The action of recombinant-human-erythropoietin (RHE) on platelet and red-cell function in chronic-renal-failure patients on hemodialysis. Terapevticheskii Arkhiv 66, 57-60.
19. TAKAHASHI, S., YANAI, M. & OKADA, K. (1995). Recombinant human erythropoietin has no direct or strong vasoconstrictor effects in vivo and in vitro. Nephrology Dialysis Transplantation 10, 815-820.
20. TSUKAHARA, H., HIRAOKA, M., HORI, C., HATA, I., OKADA, T., GEJYO, F. & SUDO, M. (1997). Chronic erythropoietin treatment enhances endogenous nitric oxide production in rats. Scandinavian Journal of Clinical & Laboratory Investigation 57, 487-493.
21. VAZIRI, N. D., ZHOU, X. J., NAQVI, F., SMITH, J., OVEISI, F., WANG, Z. Q. & PURDY, R. E. (1996). Role of nitric-oxide resistance in erythropoietin-induced hypertension in rats with chronic-renal-failure. American Journal of Physiology 271, E113-122.
22. VAZIRI, N. D., ZHOU, X. J., SMITH, J., OVEISI, F., BALDWIN, K. & PURDY, R. E. (1995). In vivo and in vitro pressor effects of erythropoietin in rats. American Journal of Physiology 269, F838-845.
23. WU, X. C., JOHNS, E. J. & RICHARDS, N. T. (1996). Erythropoietin (EPO) inhibits contractions of human renal interlobular arteries in vitro. Nephrology Dialysis Transplantation 11, A67.
24. WU, X. C., RICHARDS, N. T. & JOHNS, E. J. (1999). Role of erythropoietin and nitric oxide in modulating tone of human renal interlobular and subcutaneous arteries from uraemic man. Clinical Science (in the Press).
25. WU, X. C., RICHARDS, N. T., MICHAEL, J. & JOHNS, E. (1994). Relative roles of nitric-oxide and cyclooxygenase and lipoxygenase products of arachidonic-acid in the contractile responses of rat renal arcuate arteries. British Journal of Pharmacology 112, 369-376.